Cho Rom Hahm1, Myoung Nam Lim2, Hee Yeong Kim3, Seok-Ho Hong4, Seon-Sook Han5, Seung-Joon Lee5, Woo Jin Kim5, Yoonki Hong5. 1. Department of School of Medicine, Kangwon National University, Chuncheon, Korea ; 2. Department of Respiratory Center, Kangwon National University Hospital, Chuncheon, Korea ; 3. Department of Radiology, Kangnam Sacred Heart Hospital, Hallym University Medical Center, Seoul, Korea ; 4. Stem Cell Institute, Kangwon National University, Chuncheon, Korea ; 5. Department of Internal Medicine and Environmental Health Center, Kangwon National University Hospital, Chuncheon, Korea.
Abstract
BACKGROUND: Identifying markers for predicting the course and outcome of chronic obstructive pulmonary disease (COPD) remains important. The relative pulmonary artery enlargement to aorta ratio (PA-A ratio), which is measured using computed tomography (CT), is a reported predictor for COPD exacerbation and mortality. However, little is known about the implications of the PA-A ratio in patients with mild COPD. METHODS: We investigated the utility of the PA-A ratio as a biomarker in patients with relatively mild COPD. A total of 131 patients with mild to moderate COPD [post-bronchodilator forced expiratory volume in 1 sec (FEV1)/forced vital capacity (FVC) 61.6±6.4, mean post-bronchodilator FEV1 83%±17.8% of predicted value] were selected from a Korean COPD cohort (from 2012 until the end of 2014) and analyzed retrospectively. We determined the correlation between the PA-A ratio and clinical parameters using a linear regression model. RESULTS: The COPD assessment test (P=0.04), FEV1 (P=0.03), and a history of exacerbation in the last year (P=0.03) were significant factors in the univariate linear regression analysis. Post-bronchodilator FEV1 was most significantly associated with the PA-A ratio in the multivariate analysis (P=0.01). CONCLUSIONS: The PA-A ratio evaluated by CT imaging was independently correlated with a representative pulmonary function factor (FEV1) in patients with relatively mild COPD. The results suggest that the PA-A ratio may be an important biomarker for clinical outcome in patients with mild COPD.
BACKGROUND: Identifying markers for predicting the course and outcome of chronic obstructive pulmonary disease (COPD) remains important. The relative pulmonary artery enlargement to aorta ratio (PA-A ratio), which is measured using computed tomography (CT), is a reported predictor for COPD exacerbation and mortality. However, little is known about the implications of the PA-A ratio in patients with mild COPD. METHODS: We investigated the utility of the PA-A ratio as a biomarker in patients with relatively mild COPD. A total of 131 patients with mild to moderate COPD [post-bronchodilator forced expiratory volume in 1 sec (FEV1)/forced vital capacity (FVC) 61.6±6.4, mean post-bronchodilator FEV1 83%±17.8% of predicted value] were selected from a Korean COPD cohort (from 2012 until the end of 2014) and analyzed retrospectively. We determined the correlation between the PA-A ratio and clinical parameters using a linear regression model. RESULTS: The COPD assessment test (P=0.04), FEV1 (P=0.03), and a history of exacerbation in the last year (P=0.03) were significant factors in the univariate linear regression analysis. Post-bronchodilator FEV1 was most significantly associated with the PA-A ratio in the multivariate analysis (P=0.01). CONCLUSIONS: The PA-A ratio evaluated by CT imaging was independently correlated with a representative pulmonary function factor (FEV1) in patients with relatively mild COPD. The results suggest that the PA-A ratio may be an important biomarker for clinical outcome in patients with mild COPD.
Entities:
Keywords:
Biomarker; chronic obstructive lung disease (COPD); computed tomography (CT); exacerbation; relative pulmonary artery to aorta ratio (PA-A ratio)
Authors: M R Miller; J Hankinson; V Brusasco; F Burgos; R Casaburi; A Coates; R Crapo; P Enright; C P M van der Grinten; P Gustafsson; R Jensen; D C Johnson; N MacIntyre; R McKay; D Navajas; O F Pedersen; R Pellegrino; G Viegi; J Wanger Journal: Eur Respir J Date: 2005-08 Impact factor: 16.671
Authors: Anand S Iyer; J Michael Wells; Sonia Vishin; Surya P Bhatt; Keith M Wille; Mark T Dransfield Journal: Chest Date: 2014-04 Impact factor: 9.410
Authors: Judith Hurdman; Robin Condliffe; Charlie A Elliot; Andrew Swift; Smitha Rajaram; Christine Davies; Catherine Hill; Neil Hamilton; Iain J Armstrong; Catherine Billings; Lauren Pollard; Jim M Wild; Allan Lawrie; Rod Lawson; Ian Sabroe; David G Kiely Journal: Eur Respir J Date: 2012-09-27 Impact factor: 16.671
Authors: Claudio Terzano; Vittoria Conti; Fabio Di Stefano; Angelo Petroianni; Daniela Ceccarelli; Elda Graziani; Salvatore Mariotta; Alberto Ricci; Antonio Vitarelli; Giovanni Puglisi; Corrado De Vito; Paolo Villari; Luigi Allegra Journal: Lung Date: 2010-01-12 Impact factor: 2.584
Authors: Sang Hoon Lee; Young Jae Kim; Hye Jeong Lee; Hee Yeong Kim; Young Ae Kang; Moo Suk Park; Young Sam Kim; Se Kyu Kim; Joon Chang; Ji Ye Jung Journal: PLoS One Date: 2015-05-08 Impact factor: 3.240